2022
Comparison of the Effect on Vessel Density and RNFL between Carteolol and Latanoprost
NUTTEROVÁ, Elena; Martin FUS; Libuse BARTOSOVA; Iva KLIMESOVA; Jan LESTAK et. al.Základní údaje
Originální název
Comparison of the Effect on Vessel Density and RNFL between Carteolol and Latanoprost
Autoři
NUTTEROVÁ, Elena; Martin FUS; Libuse BARTOSOVA; Iva KLIMESOVA a Jan LESTAK
Vydání
Journal of Clinical Medicine, Basel, MDPI, 2022, 2077-0383
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.900
Organizační jednotka
Lékařská fakulta
UT WoS
000833373300001
Klíčová slova anglicky
hypertensive glaucoma; OCTA; vessel density; RNFL; treatment with carteolol and latanoprost
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 27. 9. 2022 14:24, Mgr. Tereza Miškechová
Anotace
V originále
The aim of the study was to compare the treatment of hypertensive glaucoma (HTG) in the early stages with carteolol and latanoprost by assessing the change in vessel density (VD) and retinal nerve fibre layer (RNFL). Methods: The first group with diagnosed HTG consisted of 46 eyes treated with carteolol; the second group consisted of 52 eyes treated with latanoprost. The following examinations were evaluated in all patients: intraocular pressure (IOP), retinal nerve fibre layer (RNFL), vessel density (VD) and visual field examination (glaucoma fast threshold test). The results were compared before treatment and 3 months after treatment. Results: There was no difference in the overall visual field defect (OD) between groups before treatment. After treatment, there was a decrease in IOP in both groups (carteolol-treated group had a mean decrease of 5.8 mmHg and latanoprost-treated eyes had a mean decrease of 7 mmHg). This difference was not statistically significant (p = 0.133). No similar difference was observed for RNFL (p = 0.161). In contrast, the change in the VD parameter was statistically significant between groups (p < 0.05), with a greater difference observed in the carteolol-treated group of eyes. Carteolol had a better effect on the VD.